On November 17, 2020, MedAvail Holdings Inc. (f k a MYOS RENS Technology Inc.), consummated the previously announced business combination pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of June 30, 2020, by and among the company, MedAvail Inc. (MedAvail), and Matrix Merger Sub Inc. (Merger Sub). Pursuant to the Merger Agreement, Merger Sub merged with and into MedAvail, with MedAvail surviving as a wholly-owned subsidiary of the Company. The Business Combination was consummated on November 18, 2020. In connection with the consummation of the Business Combination, the registrant changed its name from MYOS RENS Technology Inc. to MedAvail Holdings Inc. Pursuant to the Merger Agreement, on November 17, 2020, MYOS terminated the employment of Mr. Mannello, MYOS's Chief Executive Officer. On November 17, 2020, effective as of the Effective Time, the MYOS Board appointed Ed Kilroy as the company's Chief Executive Officer.